Innehåll

  • Allmänt

  • Week topics material

    Begränsad Endast tillgängligt om
    • du tillhör grupp All students
    • du tillhör grupp Teachers

    Here, you will find preparatory material for self-studies, lectures, articles etc for all week-topics.

  • Portfolio

    Begränsad Endast tillgängligt om
    • du tillhör grupp All students
    • du tillhör grupp Teachers

    The course portfolio consists of two written research proposals, peer-review, reflection on peer-review and a final seminar where research proposal 2 is presented and evaluated.

    Deadlines
    • 22/11   Submit RP1 for peer review
    • 27/11   Submit completed peer review
    •   4/12   Final submission RP1
    •   6/12   Submit reflection on peer review process
    •   9/1     Submit RP2
    • 14-15/1 Oral presentation of RP2

    How to write a research proposal:

    Instructions for the assignment on writing a research proposal. 

    Note that for Research proposal 2, you should add a 2-year budget for the project. Place the budget on a separate page at the end of the pdf document.

    Instructions and examples are given here.


    Peer review:

    Instructions for peer-review 

    Teacher assessment of you given peer-review is according to the following assessment criteria.


    Examples

    Example research proposal and corresponding teacher evaluation.


    Reflection

    Instructions for reflection.

  • Presentation of Research proposal 2

    The presentations of Research proposal 2 are held Jan 14-15. You have to attend both days, one as a presenter and one as part of the review board.

    Instructions for presenters and review board are found here.


    Schedule for Research Proposal 2: 10 min presentation + 5 min discussion 


    Tuesday 14/1 (Anna-Karin Larsson Callerfelt)

    09.00-09.15     1. Eldina Kurtisi - “Montelukast, a antagonist for Cysteine Leukotriene Receptor 1 (CysLT1R) to inhibit colon cancer cell migration in vitro”

    09.15-09.30     2. Stina Lagerström - “Targeting HTT in induced neurons directly reprogrammed from Huntingdon’s disease patient fibroblasts using CRIPSRi”       

    09.30-09.45     3. Karin Lindefalk - “Connexin 43 and its role as a potential key player in the pathogenesis of pulmonary hypertension”

    09.45-10.00     4. Agnes Lindholm - “Osthole: A new possible anticancer agent in the treatment of Triple-Negative Breast Cancer”

    10.00-10.10     Paus

    10.10-10.25     5. Neele Bergemann - “Persistent Eosinophilic Asthma: Dupilumab As an Inhibitor of the Th2-Inflammatory Pathway – A Phase IIa Study” 

    10.25-10.40     6. Carol Geukens - “Ultrasound mediated chemotherapy as a more local treatment for lung cancer”

    10:40-10.55     7. Emma Korhonen - “The use of oral theophylline to increase corticosteroid sensitivity in patients with chronic obstructive pulmonary disease: a randomized double-blind clinical trial”

    10:55-11.10     8. Sofia Thomasson - “Can pulmonary exposure to cellulose nanocrystals have any harmful effect on reproductive system in male mice”

    11.10-11.25     9. Anthony Troung - “Treating Lung cancer using autologous cytokine-induced killer cell therapy”

    11.30-11.50     Reviewer board discussions. Decision of 3 project grants for support

    11.50-12.00    Grant Decisions and concluding comments 

     

    Wednesday 15/1 (Maria Swanberg) 

    9.00-9.15         1. Elin von Horn - “Evaluation of MK-1439 a new NNRT1 for the treatment of HIV-1 infection”

    9.15-9.30         2. Emma Angsås - “Using the Bcl-3 inhibitor A27 to induce anti-tumorigenic effects in triple-negative breast cancer”

    9.30-9.45         3. Ivana Milas - “Targeting free Prostate Specific Antigen for imaging of prostate cancer and the effect on increased radiolabeling on antibody internalization”

    09.45-10.00    4.  Francisko Olofsson Falla - “Being able to decrease PARPi resistance and at the same time increase cytotoxicity effects for a TNBC future treatment”

    10.00-10.15      Paus

    10.15-10.30     5. Andrietta Grentzmann - “The Characterization of Biomarkers in Sepsis-caused Organ Damage in Mice could lead to Targeted Treatments in Severe Sepsis”

    10.30-10.45     6. Malin Hagland – “Classification of intra-host viral sequence diversity of HIV-1 infections using Primer-ID deep sequencing”

    10.45-11.00    7. Jolijn Italianer – “Regulating NET formation in lung tissue could present a possible treatment target for ARDS patients”

    11.00-11.15.   8. Louise Thelaus – “A new Insight in Treating Acute Myeloid Leukemia (AML) by Specifically Targeting CD123 on AML Cells While Sparing Normal Bone Marrow Cells”

    11.20-11.40      Reviewer board discussions. Decision of 3 project grants for support

    11.40-11.50      Grant Decisions and concluding comments

    11.50-12.10      Time for questions regarding the written exam on Friday

     


  • Information on written examination

    Begränsad Endast tillgängligt om
    • du tillhör grupp All students
    • du tillhör grupp Teachers

    Written examination:

    Friday January 17th at 9.00-13.00. 

    Re-exam:

    TBD.

    The written examination will be in the form of multiple choice questions (MCQ) with a singel best answer. There will be 10 MCQ per week topic, 80 questions in total. Old exams with correction guide are found at the links below

    Re-exam Februry 2018

    Re-exam Februry 2018 with correct answers

    Exam Jan 2019

    Exam Jan 2019 with correct answers

    Exam Jan 2018.

    Exam Jan 10 2017.

    Exam Feb 1 2017.

  • Students and groups

    Begränsad Endast tillgängligt om
    • du tillhör grupp All students
    • du tillhör grupp Teachers

    Grupp A: Neele Bergemann, Ivana Milas, Elin von Horn, Antony Truong, Carol Geukens and Andrietta Grentzmann

    Grupp B: Stina Lagerström, Malin Hagland, Eldina Kurtisi, Jolijn Italianer, Emma Angsås and Emma Korhonen

    Grupp C: Louise Thelaus, Agnes Lindholm, Sofia Thomasson, Karin Linderfalk and Francisco Olofsson Falla